Medicine Recommendations

Heart failure, hypertension, diabetic nephropathy and prophylaxis of cardiovascular events

Schizophrenia and other psychoses, mania, short term management of severe anxiety, psychomotor agitation, violent or dangerously impulsive behaviour

The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.

Depressive illness

The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.

Hypertensive episodes in phaeochromocytoma

Topical treatment for atopic eczema (NICE TA 82)

NICE TA82 - Tacrolimus and pimecrolimus for atopic eczema 

Psoriasis

Schizophrenia, monosymptomatic hypochondriacal psychosis, paranoid psychosis

The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.

Type 2 diabetes

Hypersalivation Unlicensed

Treatment of narcolepsy with or without cataplexy in adults.

Restless Legs Syndrome (as per LSCMMG Guidelines)

Vulvovaginal or vaginal atrophy in postmenopausal women having moderate to severe symptoms

with percutaneous coronary intervention for treating acute coronary syndromes (review of technology appraisal guidance 182) (NICE TA317)

NICE TA317 Prasugrel with percutaneous coronary intervention for treating acute coronary syndromes (review of technology appraisal guidance 182)

MHRA Drug Safety Update - Prasugrel: rare but serious hypersensitivity reactions 

Giant Cell Arteritis

Cluster Headache

Acute Gout (as per LSCMMG Guidelines)

Neuropathic pain

Prescribing of Pregabalin for the treatment of Generalised Anxiety Disorder (GAD)

Neuropathic pain (as per LSCMMG Guidelines)

Restless Legs Syndrome (off-licence as per LSCMMG Guidelines)